A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
Clinical trial NCT06073860 · RECRUITING
Trial details
- NCT number
- NCT06073860
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-25
- Primary completion
- 2027-12-21
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.